• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    US Stocks Mostly Higher; Headline PCE Inflation Matches Estimates

    5/31/24 10:03:34 AM ET
    $CLDI
    $LUCY
    $NVOS
    $SIFY
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Ophthalmic Goods
    Health Care
    Get the next $CLDI alert in real time by email

    U.S. stocks traded mostly higher this morning, with the Dow Jones index gaining around 75 points on Friday.

    Following the market opening Friday, the Dow traded up 0.20% to 38,187.97 while the NASDAQ rose 0.05% to 16,745.67. The S&P 500 also rose, gaining, 0.19% to 5,245.55.

    Check This Out: Cirrus Logic, Texas Roadhouse And 2 Other Stocks Insiders Are Selling

    Leading and Lagging Sectors

    Energy shares rose by 0.9% on Friday.

    In trading on Friday, consumer staples shares fell by 0.1%.

    Top Headline

    The Federal Reserve's preferred inflation measure held steady in April, aligning with economist expectations, yet keeping investors anxious about potential rate cuts.

    The headline PCE inflation rate held steady at 2.7% year-on-year in April 2024, matching economist expectations, according to Econoday data.

    Equities Trading UP
                           

    • Novo Integrated Sciences, Inc. (NASDAQ:NVOS) shares shot up 137% to $1.07 after the company approved a $5 million stock repurchase. The company’s board is conducting a review to determine whether it is appropriate to increase the amount under the repurchase program.
    • Shares of XChange Tec Inc (NASDAQ:XHG) got a boost, surging 45% to $0.9901 after dipping 15% on Thursday.
    • Innovative Eyewear, Inc. (NASDAQ:LUCY) shares were also up, gaining 45% to $1.1500. Innovative Eyewear recently launched its Eddie Bauer Smart Eyewear collection.

    Equities Trading DOWN

    • Sify Technologies Limited (NASDAQ:SIFY) shares dropped 38% to $1.04 after gaining over 8% on Thursday.
    • Shares of Smart for Life, Inc. (NASDAQ:SMFL) were down 36% to $3.83.
    • Calidi Biotherapeutics, Inc (NYSE:CLDI) was down, falling 28% to $0.2155 after the company reported exercise of warrants for $2.1 million gross proceeds.

    Also Check This Out: How To Earn $500 A Month From Pfizer Stock

    Commodities

    In commodity news, oil traded up 0.2% to $78.06 while gold traded up 0.4% at $2,376.80.

    Silver traded up 0.6% to $31.720 on Friday, while copper fell 0.3% to $4.6455.

    Euro zone

    European shares were mostly higher today. The eurozone's STOXX 600 rose 0.4%, Germany's DAX gained 0.2% and France's CAC 40 gained 0.2%. Spain's IBEX 35 Index slipped 0.1%, while London's FTSE 100 gained 0.6%.

    Annual inflation rate in the Eurozone increased to 2.6% in May compared to 2.4% in each of the prior two months. Producer prices in France fell 3.6% month-over-month for the month of April. The French economy grew by 0.2% quarter-over-quarter in the first quarter, while annual inflation rate in France came in steady at 2.2% in May.

    Consumer credit in the UK increased by £73 million in April versus a revised £1.422 billion a month ago. Italy's gross domestic product increased by 0.3% from the prior quarter during the three months ending March. Retail sales in Germany fell 1.2% month-over-month during April.

    Asia Pacific Markets

    Asian markets closed mixed on Friday, with Japan's Nikkei gaining 1.14%, China's Composite Index falling 0.16%, Hong Kong's Hang Seng Index falling 0.83% and India's S&P BSE Sensex gaining 0.01%.

    Retail sales in Hong Kong fell 16.5% year-over-year in April compared to revised 8.7% decline in the earlier month. The NBS Composite PMI Output Index for China fell to 51.0 in May compared to April's reading of 51.7.

    Retail sales in Japan increased by 2.4% year-over-year in April, while industrial production fell 0.1% month-over-month in April. Japan’s housing starts climbed by 13.9% year-over-year in April versus a 12.8% decline in the prior month. Japan's unemployment rated came in unchanged at 2.6% in April.

    Economics

    • The headline PCE inflation rate held steady at 2.7% year-on-year in April 2024, matching economist expectations, according to Econoday data.
    • Personal income rose at a 0.3% monthly rate, slowing down from March's 0.5% growth and matching expectations.
    • Personal spending advanced at a 0.2% pace, decelerating from March's 0.8% growth and missing expectations of 0.3%.

    Now Read This: Top 5 Defensive Stocks That May Explode This Quarter

    Get the next $CLDI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CLDI
    $LUCY
    $NVOS
    $SIFY

    CompanyDatePrice TargetRatingAnalyst
    Calidi Biotherapeutics Inc.
    $CLDI
    11/22/2023$11.00Buy
    H.C. Wainwright
    Calidi Biotherapeutics Inc.
    $CLDI
    10/9/2023$9.00Outperform
    Robert W. Baird
    More analyst ratings

    $CLDI
    $LUCY
    $NVOS
    $SIFY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Gross Harrison R. bought $1,980 worth of shares (1,500 units at $1.32), increasing direct ownership by 12% to 13,733 units (SEC Form 4)

    4 - Innovative Eyewear Inc (0001808377) (Issuer)

    1/22/26 11:29:05 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Chief Financial Officer Gayle Oswald bought $1,669 worth of shares (1,000 units at $1.67), increasing direct ownership by 54% to 2,865 units (SEC Form 4)

    4 - Innovative Eyewear Inc (0001808377) (Issuer)

    1/15/26 5:00:07 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Chief Executive Officer Gross Harrison R. bought $2,400 worth of shares (1,500 units at $1.60), increasing direct ownership by 14% to 12,233 units (SEC Form 4)

    4 - Innovative Eyewear Inc (0001808377) (Issuer)

    1/12/26 5:00:39 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    $CLDI
    $LUCY
    $NVOS
    $SIFY
    SEC Filings

    View All

    Calidi Biotherapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Calidi Biotherapeutics, Inc. (0001855485) (Filer)

    2/9/26 8:08:33 PM ET
    $CLDI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 20-F filed by XChange TEC.INC

    20-F - XChange TEC.INC (0001769256) (Filer)

    1/14/26 4:31:03 PM ET
    $XHG
    Real Estate
    Finance

    SEC Form 6-K filed by Sify Technologies Limited

    6-K - SIFY TECHNOLOGIES LTD (0001094324) (Filer)

    1/12/26 11:59:34 AM ET
    $SIFY
    Computer Software: Programming Data Processing
    Technology

    $CLDI
    $LUCY
    $NVOS
    $SIFY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Calidi Biotherapeutics Provides Corporate Update and Key Value Drivers for 2026

    Company intends to file an IND in Q4 2026 for its first RedTail lead candidate, CLD-401, a systemically delivered and targeted genetic medicine engineered to deliver high concentrations of IL-15 superagonist to the tumor microenvironment in patients with metastatic disease.Calidi expects to present proof of concept data demonstrating the versatility of the RedTail platform and expanding its oncology platform with new payloads including the simultaneous delivery of tumor-localized BiTEs alongside T-cell amplifiers.Calidi expects to present proof of concept data demonstrating the applicability of the RedTail platform in non-oncology indications. SAN DIEGO, Jan. 28, 2026 (GLOBE NEWSWIRE) --

    1/28/26 8:00:00 AM ET
    $CLDI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Innovative Eyewear, Inc. 2025 Year in Review

    MIAMI, Jan. 22, 2026 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (NASDAQ: LUCY; LUCYW), the developer and manufacturer of smart eyewear under the Lucyd®, Lucyd Armor®, Reebok®, Eddie Bauer® and Nautica® brands, is pleased to announce a summary of the Company's progress and achievements throughout 2025. The Company believes these developments have significantly advanced its goal of building the global standard in smart eyewear. Global Market Expansion & Strategic Partnerships Innovative Eyewear executed a focused distribution strategy in 202

    1/22/26 8:30:00 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Sify reports Consolidated Financial Results for Q3 FY 2025-26

    Revenues of INR 11596 Million. EBITDA of INR 2470 Million. Loss for the period INR 329 Million. CHENNAI, India, Jan. 12, 2026 (GLOBE NEWSWIRE) -- DETAILS OF EARNING CALL         January 13, 2026 | 8:30 AM ET | 07:00 PM IST Participant Dial in: To join: +1-888-506-0062 (Toll Free in the U.S. or Canada) or +1-973-528-0011 (International) | Access Code: 910873 On the call: Mr. Raju Vegesna, Chairman of the Board and Mr. M P Vijay Kumar, Executive Director & Group CFO Live webcast: https://www.webcaster4.com/Webcast/Page/2184/53449. Archives: +1-877-481-4010 (Toll Free in the U.S. or Canada) or +1-919-882-2331 (International). Passcode 53449 Replay is available unti

    1/12/26 8:45:23 AM ET
    $SIFY
    Computer Software: Programming Data Processing
    Technology

    $CLDI
    $LUCY
    $NVOS
    $SIFY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Gross Harrison R. bought $1,980 worth of shares (1,500 units at $1.32), increasing direct ownership by 12% to 13,733 units (SEC Form 4)

    4 - Innovative Eyewear Inc (0001808377) (Issuer)

    1/22/26 11:29:05 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Chief Financial Officer Gayle Oswald bought $1,669 worth of shares (1,000 units at $1.67), increasing direct ownership by 54% to 2,865 units (SEC Form 4)

    4 - Innovative Eyewear Inc (0001808377) (Issuer)

    1/15/26 5:00:07 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Chief Executive Officer Gross Harrison R. bought $2,400 worth of shares (1,500 units at $1.60), increasing direct ownership by 14% to 12,233 units (SEC Form 4)

    4 - Innovative Eyewear Inc (0001808377) (Issuer)

    1/12/26 5:00:39 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    $CLDI
    $LUCY
    $NVOS
    $SIFY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    H.C. Wainwright initiated coverage on Calidi Biotherapeutics with a new price target

    H.C. Wainwright initiated coverage of Calidi Biotherapeutics with a rating of Buy and set a new price target of $11.00

    11/22/23 7:15:52 AM ET
    $CLDI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Robert W. Baird initiated coverage on Calidi Biotherapeutics with a new price target

    Robert W. Baird initiated coverage of Calidi Biotherapeutics with a rating of Outperform and set a new price target of $9.00

    10/9/23 7:23:07 AM ET
    $CLDI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $CLDI
    $LUCY
    $NVOS
    $SIFY
    Financials

    Live finance-specific insights

    View All

    Sify Technologies to announce Financial Results for Third Quarter FY 2025-26 on Monday, January 12, 2026

    CHENNAI, India, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Sify Technologies Limited (NASDAQ:SIFY), India's leading Digital ICT solutions provider with global service capabilities spanning Data Center, Cloud, Networks, Security and Digital services, today announced that it will report its unaudited IFRS financial results for the third quarter ended December 31, 2025 on Monday, January 12, 2026 before the market opens.  The following Tuesday, January 13, 2026, Sify will host a conference call at 8:30 AM ET with Mr. Raju Vegesna, Chairman of the Board and Mr. M P Vijay Kumar, Executive Director & Group CFO. Interested parties may participate by dialling +1-888-506-0062 (Toll Free in the U.S. or Cana

    1/5/26 7:49:53 AM ET
    $SIFY
    Computer Software: Programming Data Processing
    Technology

    Sify Technologies to announce Financial Results for Second Quarter FY 2025-26 on Saturday, October 25, 2025

    CHENNAI, India, Oct. 18, 2025 (GLOBE NEWSWIRE) -- Sify Technologies Limited (NASDAQ:SIFY), India's leading Digital ICT solutions provider with global service capabilities spanning Data Center, Cloud, Networks, Security and Digital services, today announced that it will report its unaudited IFRS financial results for the second quarter ended September 30, 2025 on Saturday, October 25, 2025 before the market opens.  The following Monday, October 27, 2025, Sify will host a conference call at 8:30 AM ET with Mr. Raju Vegesna, Chairman of the Board and Mr. M P Vijay Kumar, Executive Director & Group CFO. Interested parties may participate by dialling +1-888-506-0062 (Toll Free in the U.S. or C

    10/18/25 12:34:04 PM ET
    $SIFY
    Computer Software: Programming Data Processing
    Technology

    Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights

    Presented preclinical data at the American Society of Clinical Oncology (ASCO) on CLD-401 demonstrating biological efficacy IL-15 superagonist delivery to metastatic tumor sites and reduced immune clearance through engineered CD55 membrane expression; IND filing expected by the end of 2026Received FDA Fast Track Designation for CLD-201, a first-in-class stem-cell loaded intratumoral viral therapy for the treatment of patients with soft tissue sarcomaRaised $4.6 million gross proceeds through a warrant inducement offering with existing investors that further strengthens the company's balance sheet and extends its runway SAN DIEGO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics

    8/8/25 4:15:00 PM ET
    $CLDI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $CLDI
    $LUCY
    $NVOS
    $SIFY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Smart for Life Inc.

    SC 13G/A - SMART FOR LIFE, INC. (0001851860) (Subject)

    11/14/24 6:49:12 PM ET
    $SMFL
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13G/A filed by Calidi Biotherapeutics Inc.

    SC 13G/A - Calidi Biotherapeutics, Inc. (0001855485) (Subject)

    11/14/24 2:05:25 PM ET
    $CLDI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Innovative Eyewear Inc.

    SC 13G/A - Innovative Eyewear Inc (0001808377) (Subject)

    11/13/24 11:18:48 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    $CLDI
    $LUCY
    $NVOS
    $SIFY
    Leadership Updates

    Live Leadership Updates

    View All

    Calidi Biotherapeutics Provides Corporate Update and Key Value Drivers for 2026

    Company intends to file an IND in Q4 2026 for its first RedTail lead candidate, CLD-401, a systemically delivered and targeted genetic medicine engineered to deliver high concentrations of IL-15 superagonist to the tumor microenvironment in patients with metastatic disease.Calidi expects to present proof of concept data demonstrating the versatility of the RedTail platform and expanding its oncology platform with new payloads including the simultaneous delivery of tumor-localized BiTEs alongside T-cell amplifiers.Calidi expects to present proof of concept data demonstrating the applicability of the RedTail platform in non-oncology indications. SAN DIEGO, Jan. 28, 2026 (GLOBE NEWSWIRE) --

    1/28/26 8:00:00 AM ET
    $CLDI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Sify reports Consolidated Financial Results for Q3 FY 2025-26

    Revenues of INR 11596 Million. EBITDA of INR 2470 Million. Loss for the period INR 329 Million. CHENNAI, India, Jan. 12, 2026 (GLOBE NEWSWIRE) -- DETAILS OF EARNING CALL         January 13, 2026 | 8:30 AM ET | 07:00 PM IST Participant Dial in: To join: +1-888-506-0062 (Toll Free in the U.S. or Canada) or +1-973-528-0011 (International) | Access Code: 910873 On the call: Mr. Raju Vegesna, Chairman of the Board and Mr. M P Vijay Kumar, Executive Director & Group CFO Live webcast: https://www.webcaster4.com/Webcast/Page/2184/53449. Archives: +1-877-481-4010 (Toll Free in the U.S. or Canada) or +1-919-882-2331 (International). Passcode 53449 Replay is available unti

    1/12/26 8:45:23 AM ET
    $SIFY
    Computer Software: Programming Data Processing
    Technology

    Sify reports Consolidated Financial Results for Q2 FY 2025-26

    Revenues of INR 10,533 Million. EBITDA of INR 2,361 Million. Loss for the period INR 275 Million. CHENNAI, India, Oct. 25, 2025 (GLOBE NEWSWIRE) -- DETAILS OF EARNING CALL                         October 27, 2025| 8:30 AM ET | 06:00 PM IST Participant Dial in: To join: +1-888-506-0062 (Toll Free in the U.S. or Canada) or +1-973-528-0011 (International) | Access Code: 910873 On the call: Mr. Raju Vegesna, Chairman of the Board and Mr. M P Vijay Kumar, Executive Director & Group CFO Live webcast: https://www.webcaster4.com/Webcast/Page/2184/53133 Archives: +1-877-481-4010 (Toll Free in the U.S. or Canada) or +1-919-882-2331 (International). Passcode 53133 Replay is available until

    10/25/25 10:44:44 AM ET
    $SIFY
    Computer Software: Programming Data Processing
    Technology